| [1] |
Harper A, Vijayakumar V, Ouwehand AC, et al. Viral infections, the microbiome, and probiotics[j]. Front Cell Infect Microbiol, 2021, 10: 596166. DOI: 10.3389/fcimb.2020.596166.
|
| [2] |
Sharifi-Rad J, Rodrigues CF, Stojanović-Radić Z, et al. Probiotics: versatile bioactive components in promoting human health[J]. Medicina, 2020, 56(9): 433. DOI: 10.3390/medicina56090433.
|
| [3] |
Zhou A, Lei Y, Tang L, et al. Gut microbiota: the emerging link to lung homeostasis and disease[J]. J Bacteriol, 2021, 203(4): e00454-20. DOI: 10.1128/JB.00454-20.
|
| [4] |
Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis[J]. Mucosal Immunol, 2019, 12(4): 843-850. DOI: 10.1038/s41385-019-0160-6.
|
| [5] |
Hill C, Guarner F, Reid G, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J]. Nat Rev Gastroenterol Hepatol, 2014, 11(8): 506-514. DOI: 10.1038/nrgastro.2014.66.
|
| [6] |
|
| [7] |
|
| [8] |
Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, et al. Mechanisms of action of probiotics[J]. Adv Nutr, 2019, 10(suppl_1): S49-S66. DOI: 10.1093/advances/nmy063.
|
| [9] |
Van den Akker CHP, Van Goudoever JB, Shamir R, et al. Probiotics and preterm infants: a position paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics[J]. J Pediatr Gastroenterol Nutr, 2020, 70(5): 664-680. DOI: 10.1097/MPG.0000000000002655.
|
| [10] |
Poindexter B, Cummings J, Hand I, et al. Use of probiotics in preterm infants[J]. Pediatrics, 2021, 147(6): e2021051485. DOI: 10.1542/peds.2021-051485.
|
| [11] |
Rangelova VR, Raycheva RD, Kevorkyan AK, et al. Ventilator-associated pneumonia in neonates admitted to a tertiary care NICU in Bulgaria[J]. Front Pediatr, 2022, 10: 909217. DOI: 10.3389/fped.2022.909217.
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
刘雅文．益生菌制剂预防呼吸机相关性肺炎的Meta分析[D]. 南昌：南昌大学，2018.
|
| [16] |
|
| [17] |
Permall DL, Pasha AB, Chen X, et al. The lung microbiome in neonates[J]. Turk J Pediatr, 2019, 61(6): 821-830. DOI: 10.24953/turkjped.2019.06.001.
|
| [18] |
Li Y, He L, Zhao Q, et al. Microbial and metabolic profiles of bronchopulmonary dysplasia and therapeutic effects of potential probiotics Limosilactobacillus reuteri and Bifidobacterium bifidum[J]. J Appl Microbiol, 2022, 133(2): 908-921. DOI: 10.1111/jam.15602.
|
| [19] |
Qu Y, Guo S, Liu Y, et al. Association between probiotics and bronchopulmonary dysplasia in preterm infants[J]. Sci Rep, 2021, 11(1): 1-6. DOI: 10.1038/s41598-021-96489-z.
|
| [20] |
范佳英．早产儿肠道菌群变化与支气管肺发育不良症的相关研究[D]. 苏州：苏州大学，2020.
|
| [21] |
Chen SM, Lin CP, Jan MS. Early gut microbiota changes in preterm infants with bronchopulmonary dysplasia: a pilot case-control study[J]. Am J Perinatol, 2021, 38(11): 1142-1149. DOI: 10.1055/s-0040-1710554.
|
| [22] |
Yang K, Dong W. Perspectives on probiotics and bronchopulmonary dysplasia[J]. Front Pediatr, 2020, 8: 570247. DOI: 10.3389/fped.2020.570247.
|
| [23] |
|
| [24] |
Krusche J, Basse S, Schaub B. Role of early life immune regulation in asthma development[J]. Semin Immunopathol, 2020, 42(1): 29-42. DOI: 10.1007/s00281-019-00774-z.
|
| [25] |
Wu Z, Mehrabi Nasab E, Arora P, et al. Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4/NF-kB signaling pathway[J]. J Transl Med, 2022, 20(1): 1-14. DOI: 10.1186/s12967-022-03337-3.
|
| [26] |
Altman MC, Beigelman A, Ciaccio C, et al. Evolving concepts in how viruses impact asthma: a Work Group Report of the Microbes in Allergy Committee of the American Academy of Allergy, Asthma & Immunology[J]. J Allergy Clin Immunol, 2020, 145(5): 1332-1344. DOI: 10.1016/j.jaci.2019.12.904.
|
| [27] |
|
| [28] |
曾双志，秦微，谭稻香，等. 肠道菌群制剂对新生儿哮喘57例防治效果观察[J]. 现代诊断与治疗，2015, 26(13): 2956-2957.
|
| [29] |
Sestito S, D′Auria E, Baldassarre ME, et al. The role of prebiotics and probiotics in prevention of allergic diseases in infants[J]. Front Pediatr, 2020, 8: 583946. DOI: 10.3389/fped.2020.583946.
|
| [30] |
Manna S, Chowdhury T, Chakraborty R, et al. Probiotics-derived peptides and their immunomodulatory molecules can play a preventive role against viral diseases including COVID-19[J]. Probiotics Antimicrob Proteins, 2021, 13(3): 611-623. DOI: 10.1007/s12602-020-09727-7.
|
| [31] |
Monteiro CRAV, do Carmo MS, Melo BO, et al. In vitro antimicrobial activity and probiotic potential of Bifidobacterium and Lactobacillus against species of clostridium[J]. Nutrients, 2019, 11(2): 448. DOI: 10.3390/nu11020448.
|
| [32] |
Du T, Lei A, Zhang N, et al. The beneficial role of probiotic Lactobacillus in respiratory diseases[J]. Front Immunol, 2022, 13: 908010. DOI: 10.3389/fimmu.2022.908010.
|
| [33] |
Chen J, Chen X, Ho CL. Recent development of probiotic Bifidobacteria for treating human diseases[J]. Front Bioeng Biotechnol, 2021, 9: 770248. DOI: 10.3389/fbioe.2021.770248.
|